Omkar Spl.Chem. (OMKARCHEM)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Still generating ₹4 Cr quarterly sales, so the operations have not completely shut down.
• Small market cap of ₹10 Cr means a modest absolute profit could create large percentage upside if a genuine turnaround occurs.
• Listed on NSE/BSE with a transparent price, allowing investors to monitor and exit easily.

Concerns

• Negative book value of -₹83.01 indicates an insolvent balance sheet with no asset cushion.
• Sales fell 49.18% and latest quarter shows a ₹3 Cr net loss on just ₹4 Cr of revenue.
• Piotroski F-score of 2/9 and ROCE of -10.53% point to severe financial distress and capital destruction.
• Promoter holding of only 14.71% raises governance and alignment concerns.

AI Analysis

Let's start with what I can trust. A business with negative book value of ₹83.01 per share has liabilities exceeding assets. Benjamin Graham would say the margin of safety is absent—there is no cushion. Omkar Spl.Chem has a market cap of ₹10 Cr, but the balance sheet is inverted. The latest quarter tells the story: sales of only ₹4 Cr and a net loss of ₹3 Cr. Over the year, sales fell 49.18% and profit growth is -27.19%. This is not a setback; it is a contraction. ROCE is -10.53%, so existing capital is not earning a return; it is being destroyed. The Piotroski score of 2/9 is a score of distress. The reported ROE of 7.73% is misleading because it is the result of negative equity, not real profitability. Debt-to-equity cannot be calculated, which itself tells me the balance sheet is beyond conventional analysis. Promoter holding of 14.71% is too low for comfort—I like owners who eat their own cooking, especially in a small company. There is no dividend, no positive earnings, and no reason to calculate a P/E. At ₹3.95, the stock looks like a penny stock, and the 52-week range of ₹3.35 to ₹7.59 shows it is a speculative, falling knife. A true turnaround would require fresh equity, a credible restructuring plan, and a return to positive cash flows. I need evidence of at least one quarter of operational improvement before I even think about an entry. This is not value; it is hope. As Graham said, the intelligent investor is a realist who sells to optimists. I will stay away until fundamentals repair.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer